Laxeerdrank Linn

Lactulose, the active ingredient in Laxeerdrank Linn, is an osmotic laxative presented as an oral solution for oral use. It treats constipation and hepatic encephalopathy in adult patients, helping to soften stool and reduce ammonia absorption.

GNH USA supplies Laxeerdrank Linn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent product availability, regulatory compliance, and dedicated technical support throughout the supply chain.

Lactulose is used as an osmotic laxative to manage conditions related to impaired bowel motility and hepatic ammonia accumulation. - Constipation: softens stool and promotes regular bowel movements in adults. - Hepatic encephalopathy: lowers colonic ammonia production, improving neurological symptoms in patients with liver disease. - Prevention of ammonia buildup: reduces systemic ammonia levels, supporting long‑term management of chronic liver disease.

Lactulose may cause gastrointestinal and metabolic reactions, most of which are mild and transient.

Common Side Effects: - Flatulence: increased gas production leading to bloating. - Abdominal cramps: intermittent stomach discomfort. - Diarrhea: loose stools, especially at higher doses. - Nausea: mild queasiness after ingestion. - Bloating: sensation of fullness in the abdomen. - Taste disturbance: sweet or fermented taste perception.

Serious or Rare Side Effects: - Severe electrolyte imbalance: marked changes in sodium or potassium levels. - Dehydration: excessive fluid loss due to diarrhea. - Allergic reaction: rash, itching, or swelling indicating hypersensitivity. - Severe abdominal pain: persistent or worsening pain requiring medical evaluation. - Hypernatremia: elevated blood sodium from excessive water loss.

Before prescribing lactulose, clinicians should evaluate patient-specific factors and monitor therapy. - Renal function: assess kidney status as impaired clearance may affect fluid balance. - Electrolyte monitoring: check sodium and potassium levels during prolonged use. - Diabetes: monitor blood glucose because lactulose contains fermentable sugars. - Galactosemia: avoid use in patients with this metabolic disorder. - Hepatic impairment: adjust therapy based on severity of liver disease. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Lactulose can interact with other medications, altering efficacy or safety.

Major Interactions (Avoid): - Laxatives that cause electrolyte depletion: may exacerbate fluid and electrolyte loss. - Antidiarrheal agents (e.g., loperamide): can reduce lactulose’s osmotic effect.

Moderate Interactions (Monitor Closely): - Antibiotics altering gut flora: may change lactulose metabolism and effectiveness. - Mineral supplements (magnesium, calcium): can increase gastrointestinal side effects. - Diabetes medications: monitor glycemic control as lactulose may affect carbohydrate absorption.